News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,791 Results
Type
Article (39437)
Company Profile (249)
Press Release (654105)
Section
Business (204054)
Career Advice (2006)
Deals (35408)
Drug Delivery (93)
Drug Development (80967)
Employer Resources (169)
FDA (16141)
Job Trends (14832)
News (344932)
Policy (32481)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2538)
Accelerated approval (2)
Adcomms (20)
Allergies (77)
Alliances (49334)
ALS (75)
Alzheimer's disease (1322)
Antibody-drug conjugate (ADC) (98)
Approvals (16126)
Artificial intelligence (209)
Autoimmune disease (10)
Automation (14)
Bankruptcy (357)
Best Places to Work (11637)
BIOSECURE Act (18)
Biosimilars (92)
Biotechnology (177)
Bladder cancer (50)
Brain cancer (23)
Breast cancer (231)
Cancer (1789)
Cardiovascular disease (133)
Career advice (1670)
Career pathing (28)
CAR-T (130)
Cell therapy (373)
Cervical cancer (13)
Clinical research (65381)
Collaboration (698)
Compensation (393)
Complete response letters (18)
COVID-19 (2569)
CRISPR (31)
C-suite (178)
Cystic fibrosis (97)
Data (1711)
Decentralized trials (2)
Denatured (14)
Depression (35)
Diabetes (223)
Diagnostics (6300)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (104)
Drug pricing (94)
Drug shortages (24)
Duchenne muscular dystrophy (64)
Earnings (85713)
Editorial (27)
Employer branding (21)
Employer resources (145)
Events (111191)
Executive appointments (588)
FDA (17108)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (630)
Gene editing (85)
Generative AI (18)
Gene therapy (255)
GLP-1 (659)
Government (4366)
Grass and pollen (4)
Guidances (46)
Healthcare (18786)
Huntington's disease (22)
IgA nephropathy (19)
Immunology and inflammation (91)
Indications (23)
Infectious disease (2688)
Inflammatory bowel disease (125)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (70)
Interviews (311)
IPO (16470)
IRA (40)
Job creations (3627)
Job search strategy (1421)
Kidney cancer (9)
Labor market (26)
Layoffs (441)
Leadership (14)
Legal (7891)
Liver cancer (68)
Lung cancer (260)
Lymphoma (119)
Machine learning (2)
Management (57)
Manufacturing (245)
MASH (57)
Medical device (13284)
Medtech (13289)
Mergers & acquisitions (19343)
Metabolic disorders (580)
Multiple sclerosis (59)
NASH (16)
Neurodegenerative disease (69)
Neuropsychiatric disorders (23)
Neuroscience (1748)
NextGen: Class of 2025 (6510)
Non-profit (4476)
Northern California (2213)
Now hiring (35)
Obesity (319)
Opinion (196)
Ovarian cancer (61)
Pain (69)
Pancreatic cancer (69)
Parkinson's disease (117)
Partnered (17)
Patents (180)
Patient recruitment (80)
Peanut (45)
People (56914)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20359)
Phase II (28799)
Phase III (21444)
Pipeline (806)
Podcasts (40)
Policy (101)
Postmarket research (2563)
Preclinical (8590)
Press Release (64)
Prostate cancer (84)
Psychedelics (30)
Radiopharmaceuticals (242)
Rare diseases (335)
Real estate (5897)
Recruiting (64)
Regulatory (21994)
Reports (43)
Research institute (2314)
Resumes & cover letters (349)
Rett syndrome (2)
RNA editing (1)
RSV (36)
Schizophrenia (58)
Series A (114)
Series B (68)
Service/supplier (11)
Sickle cell disease (49)
Southern California (1888)
Special edition (13)
Sponsored (28)
Startups (3569)
State (2)
Stomach cancer (11)
Supply chain (56)
The Weekly (25)
United States (19415)
Vaccines (624)
Venture capitalists (34)
Webinars (12)
Weight loss (216)
Women's health (30)
Worklife (13)
Date
Today (167)
Last 7 days (753)
Last 30 days (2935)
Last 365 days (34348)
2025 (5688)
2024 (35219)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (717)
Alabama (48)
Alaska (7)
Arizona (212)
Arkansas (12)
Asia (37556)
Australia (6142)
California (5035)
Canada (1761)
China (414)
Colorado (230)
Connecticut (240)
Delaware (111)
Europe (80533)
Florida (742)
Georgia (172)
Idaho (57)
Illinois (465)
India (20)
Indiana (274)
Iowa (7)
Japan (126)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (59)
Maryland (771)
Massachusetts (3831)
Michigan (201)
Minnesota (347)
Mississippi (2)
Missouri (71)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (61)
New Jersey (1428)
New Mexico (27)
New York (1440)
North Carolina (868)
North Dakota (7)
Northern California (2213)
Ohio (177)
Oklahoma (13)
Oregon (32)
Pennsylvania (1144)
Puerto Rico (6)
Rhode Island (23)
South America (1093)
South Carolina (13)
South Dakota (1)
Southern California (1888)
Tennessee (83)
Texas (738)
Utah (155)
Virginia (116)
Washington D.C. (55)
Washington State (478)
West Virginia (3)
Wisconsin (44)
693,791 Results for "inflammatix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Inflammatix Receives FDA Clearance for First-in-Class TriVerity™ Test
January 21, 2025
·
7 min read
Press Releases
Inflammatix Initiates TriVerity™ for Improved Management of Emergency Department Patients with Suspected Infections (TIMED) Trial
November 11, 2024
·
5 min read
Press Releases
Inflammatix Adds Three MedTech Industry Veterans to Executive Leadership Team
October 10, 2024
·
5 min read
Press Releases
Inflammatix Secures $57 Million to Advance Novel Diagnostic for Patients with Suspected Infections or Sepsis
September 12, 2024
·
6 min read
Biotech Bay
Inflammatix Completes Technical Development for TriVerity™ Acute Infection and Sepsis Test System
Inflammatix, Inc., a pioneering molecular diagnostics company, announced today that the company has completed technical development for its TriVerity™ Acute Infection and Sepsis Test System, which includes the Myrna™ Instrument, and for the TriVerity™ Cartridge.
November 15, 2023
·
3 min read
FDA
Inflammatix Receives Breakthrough Device Designation from FDA for TriVerity™ Acute Infection and Sepsis Test System
Inflammatix, Inc. announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the company’s lead product, the TriVerity™ Acute Infection and Sepsis Test System.
November 28, 2023
·
5 min read
Press Releases
Inflammatix Presents Data at ACEP24 Showing High Diagnostic and Prognostic Accuracy of its TriVerity™ Test Regardless of Patient Immune Status
October 1, 2024
·
5 min read
Business
Inflammatix Appoints Heiner Dreismann as New Board Member
Inflammatix, a pioneering molecular diagnostics company, announced the appointment of Heiner Dreismann, PhD, as a member of the company’s board of directors.
July 10, 2023
·
2 min read
Business
Inflammatix Appoints Purvesh Khatri as Chief Scientific Officer
Inflammatix, Inc., a pioneering molecular diagnostics company, announced today the appointment of Purvesh Khatri, PhD, as Chief Scientific Officer.
June 15, 2022
·
2 min read
Business
Inflammatix Appoints Dr. Kian Beyzavi as New Board Member
Inflammatix announced today the appointment of Kian Beyzavi, PhD, as an independent member of the company’s board of directors.
November 30, 2021
·
2 min read
1 of 69,380
Next
